These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34158583)

  • 1. Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure.
    Bellagambi FG; Petersen C; Salvo P; Ghimenti S; Franzini M; Biagini D; Hangouët M; Trivella MG; Di Francesco F; Paolicchi A; Errachid A; Fuoco R; Lomonaco T
    Sci Rep; 2021 Jun; 11(1):13088. PubMed ID: 34158583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel electrochemical strategy for NT-proBNP detection using IMFET for monitoring heart failure by saliva analysis.
    Ben Halima H; Bellagambi FG; Hangouët M; Alcacer A; Pfeiffer N; Heuberger A; Zine N; Bausells J; Elaissari A; Errachid A
    Talanta; 2023 Jan; 251():123759. PubMed ID: 35952499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-ProBNP levels in saliva and its clinical relevance to heart failure.
    Foo JY; Wan Y; Kostner K; Arivalagan A; Atherton J; Cooper-White J; Dimeski G; Punyadeera C
    PLoS One; 2012; 7(10):e48452. PubMed ID: 23119023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
    Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure.
    Porcel JM; Bielsa S; Morales-Rull JL; Civit C; Cao G; Light RW; Esquerda A
    Respirology; 2013 Apr; 18(3):540-5. PubMed ID: 23278975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
    Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS
    PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure Results from the International Collaborative of NT-proBNP (ICON) Study.
    Baggish AL; van Kimmenade R; Bayes-Genis A; Davis M; Lainchbury JG; Frampton C; Pinto Y; Richards MA; Januzzi JL
    Clin Chim Acta; 2007 Jun; 381(2):145-50. PubMed ID: 17445789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of glycosylation on diagnostic and prognostic accuracy of N-terminal pro-B-type natriuretic peptide in acute dyspnea: data from the Akershus Cardiac Examination 2 Study.
    Røsjø H; Dahl MB; Jørgensen M; Røysland R; Brynildsen J; Cataliotti A; Christensen G; Høiseth AD; Hagve TA; Omland T
    Clin Chem; 2015 Aug; 61(8):1087-97. PubMed ID: 26056354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intracardiac concentrations of the N-terminal-pro B-type natriuretic peptide (NT-proBNP) and the determinants of its secretion in patients with atrial fibrillation.
    Streb W; Mitręga K; Szymała M; Woźniak A; Podolecki T; Kalarus Z
    Kardiol Pol; 2018; 76(2):433-439. PubMed ID: 29131295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
    Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL;
    Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.
    Zaninotto M; Mion MM; Di Serio F; Caputo M; Ottomano C; Plebani M
    Clin Chem Lab Med; 2010 Jul; 48(7):1029-34. PubMed ID: 20406130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels.
    Long AC; O'Neal HR; Peng S; Lane KB; Light RW
    Chest; 2010 Jun; 137(6):1369-74. PubMed ID: 20139229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study.
    Cortés R; Rivera M; Salvador A; Bertomeu V; de Burgos FG; Roselló-Lletí E; Portolés M; Payá R; Martínez-Dolz L; Climent V
    Heart; 2007 Aug; 93(8):957-62. PubMed ID: 17488774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cautious application of pleural N-terminal pro-B-type natriuretic peptide in diagnosis of congestive heart failure pleural effusions among critically ill patients.
    Yeh JH; Huang CT; Liu CH; Ruan SY; Tsai YJ; Chien YC; Yang CY; Huang CK; Hsu CL; Kuo LC; Lee PL; Ku SC; Kuo PH; Yu CJ;
    PLoS One; 2014; 9(12):e115301. PubMed ID: 25502236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of NT-proBNP in elderly patients with acute dyspnea: diagnostic and pronostic value].
    Méndez Bailón M; Muñoz Rivas N; Romero Román C; Pérez de Oteyza C; Conthe Gutiérrez P; Audibert Mena L
    Med Clin (Barc); 2007 Mar; 128(12):453-5. PubMed ID: 17408538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months].
    Mazovets OL; Trifonov IR; Katrukha AG; Gratsianskiĭ NA
    Kardiologiia; 2009; 49(1):34-8. PubMed ID: 19166399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
    Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
    Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
    [No Abstract]   [Full Text] [Related]  

  • 19. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.
    Leto L; Testa M; Feola M
    Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary B-type natriuretic peptide: a new method for heart failure diagnosis and follow-up.
    Joharimoghadam A; Tajdini M; Bozorgi A
    Kardiol Pol; 2017; 75(1):71-77. PubMed ID: 27296284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.